Literature DB >> 16540644

Enhanced photocarcinogenesis in interleukin-12-deficient mice.

Akira Maeda1, Stefan W Schneider, Motohiro Kojima, Stefan Beissert, Thomas Schwarz, Agatha Schwarz.   

Abstract

UV-induced DNA damage is the basis for the development of UV-mediated skin cancer because reduction of DNA damage lowers the risk for photocarcinogenesis. The cytokine interleukin (IL)-12 was shown to exhibit the capacity to reduce UV-induced DNA damage presumably via induction of nucleotide excision repair. Because IL-12 is also produced in the skin, we wondered whether endogenous IL-12 protects from photocarcinogenesis. Therefore, we used knockout mice that lack the IL-12p40 chain and thus do not secrete biologically active IL-12. IL-12p40 knockout (IL-12p40-/-) and wild-type (wt) mice were exposed thrice weekly to UV. Skin biopsies obtained after 6 weeks revealed significantly increased numbers of sunburn cells in IL-12p40-/- mice. Additionally, a higher load of UV-induced pyrimidine dimers could be detected in the skin of UV-exposed IL-12p40-/- mice. Staining of epidermal sheets with an antibody against the tumor suppressor gene p53 revealed a higher number of p53 patches in the skin of IL-12p40-/- mice. After approximately 200 days, first skin tumors developed. Kaplan-Meier analysis indicated a significantly increased probability of tumor development in the IL-12p40-/- mice. In addition, the number of tumors developing in the individual mice was significantly higher in IL-12p40-/- mice than in wt mice. Tumors obtained in IL-12p40-/- mice grew faster than those obtained from wt mice on inoculation into nu/nu mice. This was confirmed in an electrophysiologic assay evaluating the intrinsic invasive potency of tumor cells. Together, these data indicate that IL-12 deficiency is associated with an increased risk to develop UV-induced skin cancer, implying that endogenous IL-12 may protect from photocarcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16540644     DOI: 10.1158/0008-5472.CAN-05-3614

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  17 in total

Review 1.  Concordance of preclinical and clinical pharmacology and toxicology of monoclonal antibodies and fusion proteins: soluble targets.

Authors:  Pauline L Martin; Peter J Bugelski
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

Review 2.  DNA damage, apoptosis and langerhans cells--Activators of UV-induced immune tolerance.

Authors:  Laura Timares; Santosh K Katiyar; Craig A Elmets
Journal:  Photochem Photobiol       Date:  2008-01-29       Impact factor: 3.421

Review 3.  Cutaneous Manifestations of Reactions to Biologics.

Authors:  Iris M Otani; Amy S Levin; Aleena Banerji
Journal:  Curr Allergy Asthma Rep       Date:  2018-02-21       Impact factor: 4.806

4.  Effective narrow-band UVB radiation therapy suppresses the IL-23/IL-17 axis in normalized psoriasis plaques.

Authors:  Leanne M Johnson-Huang; Mayte Suárez-Fariñas; Mary Sullivan-Whalen; Patricia Gilleaudeau; James G Krueger; Michelle A Lowes
Journal:  J Invest Dermatol       Date:  2010-06-17       Impact factor: 8.551

Review 5.  Interleukin-12 and photocarcinogenesis.

Authors:  Santosh K Katiyar
Journal:  Toxicol Appl Pharmacol       Date:  2006-11-18       Impact factor: 4.219

6.  Review of ustekinumab, an interleukin-12 and interleukin-23 inhibitor used for the treatment of plaque psoriasis.

Authors:  Nora Koutruba; Jason Emer; Mark Lebwohl
Journal:  Ther Clin Risk Manag       Date:  2010-04-15       Impact factor: 2.423

7.  Silibinin inhibits ultraviolet B radiation-induced DNA-damage and apoptosis by enhancing interleukin-12 expression in JB6 cells and SKH-1 hairless mouse skin.

Authors:  Sreekanth Narayanapillai; Chapla Agarwal; Gagan Deep; Rajesh Agarwal
Journal:  Mol Carcinog       Date:  2013-01-28       Impact factor: 4.784

Review 8.  Ustekinumab: a new option in psoriasis therapy.

Authors:  Anna L Chien; James T Elder; Charles N Ellis
Journal:  Drugs       Date:  2009-06-18       Impact factor: 9.546

9.  Protective role of Toll-like receptor 4 during the initiation stage of cutaneous chemical carcinogenesis.

Authors:  Nabiha Yusuf; Tahseen H Nasti; J Alan Long; Mohammed Naseemuddin; Alan P Lucas; Hui Xu; Craig A Elmets
Journal:  Cancer Res       Date:  2008-01-15       Impact factor: 12.701

10.  Inhibition of UVB-induced skin tumor development by drinking green tea polyphenols is mediated through DNA repair and subsequent inhibition of inflammation.

Authors:  Syed M Meeran; Suhail Akhtar; Santosh K Katiyar
Journal:  J Invest Dermatol       Date:  2008-11-20       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.